Carotenoids
In clinical developmentRecent clinical, regulatory, research and industry developments relating to this drug.
The Relationship Between Lycopene and Metabolic Diseases.
An Environment-Wide Association Study (EWAS) on type 2 diabetes mellitus.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes8
Journals, researchers & institutions
- Comprehensive reviews in food science and food safety1
- Nature plants1
- Nutrients1
- Plant biotechnology journal1
- PloS one1
- An X1
- Benedetti G1
- Bhattacharya J1
- Bostan H1
- Butte AJ1
- Ceccanti C1
- Cielecka-Piontek J1
- Coe K1
- Beijing Engineering Laboratory of Main Crop Bio-Tech Breeding1
- Independent Public Clinical Hospital No. 11
- Industry Research Institute of Biotechnology Breeding1
- Institute of Natural Fibres and Medicinal Plants1
- Interdepartmental Research Center Nutrafood "Nutraceuticals and Food for Health"1
- North Carolina State University1
Related diseases
Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 5 of the same disease areas as Carotenoids in the shared literature.
Studied across the same disease area as Carotenoids in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials